Skip to content

Ocular movement disorders in Parkinson’ s disease and the response to dopaminergic drugs

Ocular movement disorders in Parkinson’ s disease and the response to dopaminergic drugs

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070333
Enrollment
Unknown
Registered
2023-04-10
Start date
2023-04-10
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Experimental group :Measuring range of eye motion
Experimental group :Levodopa challenge test
Health control :Measuring range of eye motion

Sponsors

First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with Parkinson 's disease meet 2015-MDS Parkinson 's diagnostic criteria. 2. H / Y rating of 1-4. 3. Less than 10 years of onset with no significant neck stiffness. 4. MMSE score greater than or equal to 24 points, visual and auditory normal, can cooperate to complete the test. 5. No basic ophthalmic diseases, such as eye infection, refractive error, glaucoma, cataract and other diseases.

Exclusion criteria

Exclusion criteria: 1. Cerebral hemorrhage, cerebral infarction, poisoning, trauma can lead to clear cause of Parkinson ' s disease. 2. Patients with eye infection, glaucoma, cataract, previous trauma or skin defect. 3. Patients with atypical parkinsonism, such as progressive supranuclear palsy, multiple system atrophy, corticobasal degeneration, vascular parkinsonism, dementia with Lewy bodies, etc. 4. Patients with intracranial hypertension, epilepsy, pregnant women, elderly and infirm individuals who cannot cooperate to complete the experimental operation 5. Others who could not cooperate with the experiment

Design outcomes

Primary

MeasureTime frame
upwards distance;downwards distance;leftwards distance;rightwards distance;Movement disorder society-unified-parkinson disease rating scale;

Countries

China

Contacts

Public ContactXianwen Chen

the First Affiliated Hospital of Anhui Medical University

chxwmail@aliyun.com+86 139 5693 9016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026